Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired.
Appears in 5 contracts
Samples: License Agreement (Sierra Oncology, Inc.), License Agreement (Reata Pharmaceuticals Inc), License Agreement (Osmotica Pharmaceuticals PLC)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired. Upon termination of the Royalty Term with respect to a Licensed Product in any country, the license grants to Licensee in Section 2.1, as applicable, with respect to such Licensed Product shall convert to non- exclusive and shall become fully paid-up with respect to such country.
Appears in 2 contracts
Samples: License Agreement (Arcutis Biotherapeutics, Inc.), License Agreement (Arcutis Biotherapeutics, Inc.)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product Products in any country with respect to any period after the Royalty Term for such Licensed Product in such country has expired, and any Net Sales of Licensed Products in any country with respect to any period after the Royalty Term in such country has expired shall be excluded for purposes of calculating the applicable royalty rate in Section 4.5.1.
Appears in 2 contracts
Samples: License Agreement (PhaseBio Pharmaceuticals Inc), License Agreement (PhaseBio Pharmaceuticals Inc)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country or other jurisdiction on or after the date on which the Royalty Term for such Licensed Product in such country or other jurisdiction has expired. For purposes of clarity, [***].
Appears in 2 contracts
Samples: License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Gemini Therapeutics, Inc. /DE)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired. Upon termination of the Royalty Term with respect to a Licensed Product in any country, the license grants to Licensee in Section 2.1, as applicable, with respect to such Licensed Product shall convert to non-exclusive and shall become fully paid-up with respect to such country.
Appears in 2 contracts
Samples: Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.), Confidential Treatment (Biohaven Pharmaceutical Holding Co Ltd.)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired. Upon termination of the Royalty Term with respect to a Licensed Product in any country, the license grants to Licensee in Section 2.1 (Grants to Licensee), as applicable, with respect to such Licensed Product shall become fully paid-up with respect to such country.
Appears in 2 contracts
Samples: License Agreement (Dermavant Sciences LTD), License Agreement (Dermavant Sciences LTD)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country Country after the Royalty Term for such Licensed Product in such country Country has expired.
Appears in 1 contract
Royalty Term. Licensee shall have no obligation to pay any royalty Royalty with respect to Net Sales of any Licensed Product in any country after the last day of the month in which the Royalty Term for such Licensed Product in such country has expiredexpires.
Appears in 1 contract
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any a Licensed Product in any country the Territory after the Royalty Term for such Licensed Product in such country has expired[***].
Appears in 1 contract
Samples: License and Collaboration Agreement (Cullinan Oncology, Inc.)
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired, and shall thereafter have a perpetual, paid-up license with respect to the rights granted hereunder in such country.
Appears in 1 contract
Royalty Term. Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country with respect to any period after the Royalty Term for such Licensed Product in such country has expired, and any Net Sales of Licensed Product in any country with respect to any period after the Royalty Term in such country has expired shall be excluded for purposes of calculating the applicable royalty rate in Section 5.3.1.
Appears in 1 contract
